A Clinical trial to study the effect of trial drug Jaathipalathi Chooranam on Swasakasam Bronchial Asthma

A Prospective Open Labelled non-randomized phase II clinical trial on Jaathipalathi Chooranam for the treatment of Swasakam Bronchial Asthma

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012772

Enrollment

Registered

2018-03-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Swasakasam

Interventions

Intervention1: JAATHIPALATHI CHOORANAM: 30 mg/kg/BW/thrice a day After food orally with Honey for 30 days Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Difficulty in breathing Tightness of chest wheeze Added sound rhonchi cough without expectoration History of allergy sneezing Patients who are willing to give sign in consent form and undergo laboratory investigations

Exclusion criteria

Exclusion criteria: Cardiac disease Renal disease Tuberculosis Chronic bronchitis Status asthmatics Diabetes mellitus Systemic hypertension Auto immune disease

Design outcomes

Primary

Measure	Time frame
The Therapeutic efficacy of trial drug Jaathipalathi Chooranam in SwasakasamTimepoint: 30 days	—

Secondary

Measure	Time frame
Evaluation of siddha diagnostic parameters Safety of trial drug Pharmacological and Biochemical analysis of trial drugTimepoint: 30 days	—

Countries

India

Contacts

Public ContactG Subash Chandran Md Siddha Phd

Govt Siddha Medical College and hospital Palayamkottai

siddhadrgs21@gmail.com9443358271

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026